Fetal Cardiac Disorder
8
3
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Prognostic Model of Postnatal Circulation in Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum
Effect of Fetal Aortic Valvuloplasty on Outcomes
Fetal Cardiac Remodeling in Singleton Pregnancies Conceived by Assisted Reproductive Technology (Biopsied and Non-Biopsied ICSI) Versus Those Normally Conceived
Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions
Modified Myocardial Performance Index and Epicardial Thickness in Cases With Idiopathic Polyhydramnios
Fetal Cardiac Magnetic Resonance in Detection of CHD
Fetal Cardiac Function Evaluation With aCMQ-Strain Fetal (STRAIN)